BCX4161, An Oral Kallikrein Inhibitor: Safety and Pharmacokinetic Results Of a Phase 1 Study In Healthy Volunteers

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of allergy and clinical immunology 2014-02, Vol.133 (2), p.AB39-AB39
Hauptverfasser:	Collis, Phil, Dr, Cornpropst, Melanie, Dr, Collier, Jo, Dr, Sheridan, William, Dr
Format:	Artikel
Sprache:	eng
Schlagworte:	Allergy and Immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	AB39
container_issue	2
container_start_page	AB39
container_title	Journal of allergy and clinical immunology
container_volume	133
creator	Collis, Phil, Dr Cornpropst, Melanie, Dr Collier, Jo, Dr Sheridan, William, Dr
description
doi_str_mv	10.1016/j.jaci.2013.12.162
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1566854716</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0091674913020666</els_id><sourcerecordid>1566854716</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2336-2aad53226c6a9e8ada7d8d1af5c40223922070edaf217d1f33a3961d517780e93</originalsourceid><addsrcrecordid>eNp9kVGr1DAQhYsouF79Az7l0QdbM8k2bUWE66LeixdWXBXfwphM2XSz6TVJhf57W9YnH3wahjnnwHynKJ4Dr4CDejVUAxpXCQ6yAlGBEg-KDfCuKVUr6ofFhvMOStVsu8fFk5QGvuyy7TZFfLf7sQUFL9l1YPuInn1C790pkgvsNhzdT5fH-JodsKc8MwyWfT5iPKMZTy5QdoZ9oTT5nNi-Z7geEzFghzzZeQlgN4Q-H2f2ffRTyEQxPS0e9egTPfs7r4pvH95_3d2Ud_uPt7vru9IIKVUpEG0thVBGYUctWmxsawH72my5ELITgjecLPYCGgu9lCg7BbaGpmk5dfKqeHHJvY_jr4lS1meXDHmPgcYpaaiVauttA2qRiovUxDGlSL2-j-6McdbA9QpYD3oFrFfAGoReAC-mNxcTLU_8dhR1Mo6CIesimazt6P5vf_uP3XgXnEF_opnSME4xLHg06CQ014e1wbVAkFxwpZT8A7NKlwY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1566854716</pqid></control><display><type>article</type><title>BCX4161, An Oral Kallikrein Inhibitor: Safety and Pharmacokinetic Results Of a Phase 1 Study In Healthy Volunteers</title><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Collis, Phil, Dr ; Cornpropst, Melanie, Dr ; Collier, Jo, Dr ; Sheridan, William, Dr</creator><creatorcontrib>Collis, Phil, Dr ; Cornpropst, Melanie, Dr ; Collier, Jo, Dr ; Sheridan, William, Dr</creatorcontrib><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2013.12.162</identifier><language>eng</language><publisher>Mosby, Inc</publisher><subject>Allergy and Immunology</subject><ispartof>Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB39-AB39</ispartof><rights>2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2336-2aad53226c6a9e8ada7d8d1af5c40223922070edaf217d1f33a3961d517780e93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091674913020666$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Collis, Phil, Dr</creatorcontrib><creatorcontrib>Cornpropst, Melanie, Dr</creatorcontrib><creatorcontrib>Collier, Jo, Dr</creatorcontrib><creatorcontrib>Sheridan, William, Dr</creatorcontrib><title>BCX4161, An Oral Kallikrein Inhibitor: Safety and Pharmacokinetic Results Of a Phase 1 Study In Healthy Volunteers</title><title>Journal of allergy and clinical immunology</title><subject>Allergy and Immunology</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kVGr1DAQhYsouF79Az7l0QdbM8k2bUWE66LeixdWXBXfwphM2XSz6TVJhf57W9YnH3wahjnnwHynKJ4Dr4CDejVUAxpXCQ6yAlGBEg-KDfCuKVUr6ofFhvMOStVsu8fFk5QGvuyy7TZFfLf7sQUFL9l1YPuInn1C790pkgvsNhzdT5fH-JodsKc8MwyWfT5iPKMZTy5QdoZ9oTT5nNi-Z7geEzFghzzZeQlgN4Q-H2f2ffRTyEQxPS0e9egTPfs7r4pvH95_3d2Ud_uPt7vru9IIKVUpEG0thVBGYUctWmxsawH72my5ELITgjecLPYCGgu9lCg7BbaGpmk5dfKqeHHJvY_jr4lS1meXDHmPgcYpaaiVauttA2qRiovUxDGlSL2-j-6McdbA9QpYD3oFrFfAGoReAC-mNxcTLU_8dhR1Mo6CIesimazt6P5vf_uP3XgXnEF_opnSME4xLHg06CQ014e1wbVAkFxwpZT8A7NKlwY</recordid><startdate>20140201</startdate><enddate>20140201</enddate><creator>Collis, Phil, Dr</creator><creator>Cornpropst, Melanie, Dr</creator><creator>Collier, Jo, Dr</creator><creator>Sheridan, William, Dr</creator><general>Mosby, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20140201</creationdate><title>BCX4161, An Oral Kallikrein Inhibitor: Safety and Pharmacokinetic Results Of a Phase 1 Study In Healthy Volunteers</title><author>Collis, Phil, Dr ; Cornpropst, Melanie, Dr ; Collier, Jo, Dr ; Sheridan, William, Dr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2336-2aad53226c6a9e8ada7d8d1af5c40223922070edaf217d1f33a3961d517780e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Allergy and Immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Collis, Phil, Dr</creatorcontrib><creatorcontrib>Cornpropst, Melanie, Dr</creatorcontrib><creatorcontrib>Collier, Jo, Dr</creatorcontrib><creatorcontrib>Sheridan, William, Dr</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Collis, Phil, Dr</au><au>Cornpropst, Melanie, Dr</au><au>Collier, Jo, Dr</au><au>Sheridan, William, Dr</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>BCX4161, An Oral Kallikrein Inhibitor: Safety and Pharmacokinetic Results Of a Phase 1 Study In Healthy Volunteers</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2014-02-01</date><risdate>2014</risdate><volume>133</volume><issue>2</issue><spage>AB39</spage><epage>AB39</epage><pages>AB39-AB39</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><pub>Mosby, Inc</pub><doi>10.1016/j.jaci.2013.12.162</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 0091-6749
ispartof	Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB39-AB39
issn	0091-6749 1097-6825
language	eng
recordid	cdi_proquest_miscellaneous_1566854716
source	Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects	Allergy and Immunology
title	BCX4161, An Oral Kallikrein Inhibitor: Safety and Pharmacokinetic Results Of a Phase 1 Study In Healthy Volunteers
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T00%3A16%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=BCX4161,%20An%20Oral%20Kallikrein%20Inhibitor:%20Safety%20and%20Pharmacokinetic%20Results%20Of%20a%20Phase%201%20Study%20In%20Healthy%20Volunteers&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Collis,%20Phil,%20Dr&rft.date=2014-02-01&rft.volume=133&rft.issue=2&rft.spage=AB39&rft.epage=AB39&rft.pages=AB39-AB39&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2013.12.162&rft_dat=%3Cproquest_cross%3E1566854716%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1566854716&rft_id=info:pmid/&rft_els_id=1_s2_0_S0091674913020666&rfr_iscdi=true